Eagle Pharmaceuticals, Inc.
EGRXDelisted Nov 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000827871
Eagle Pharmaceuticals, Inc. was delisted on Nov 26, 2024; its insiders filed their last Form 4 on Mar 1, 2024; 65 institutions reported holding it in 13F filings for Q3 2024, worth $31.9M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Eagle Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 146 | 1 | 151 | +6 |
| Shares | 12.0M | 8.20K | 11.8M | −213.5K (−1.8%) |
| Value | $516.0M | $351.0K | $659.5M | +$143.9M (+27.9%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Eagle Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 165,294 | $9.22M | 0.04% |
| Assenagon Asset Management S.A. | 43,043 | $2.40M | 0.01% |
| J. Goldman & Co LP | 28,528 | $1.59M | 0.14% |
| SummerHaven Investment Management, LLC | 17,742 | $990.0K | 0.58% |
| First Trust Advisors LP | 16,568 | $924.0K | 0.00% |
| HRT Financial LP | 8,791 | $490.0K | 0.00% |
| Franklin Resources Inc | 8,496 | $473.0K | 0.00% |
| American Century Companies Inc | 7,402 | $413.0K | 0.00% |
| SEI Investments Co | 6,491 | $347.0K | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 5,326 | $297.1K | 0.00% |
| Jane Street Group, LLC | 5,288 | $295.0K | 0.00% |
| Maryland State Retirement & Pension System | 4,585 | $255.0K | 0.01% |
| Voya Investment Management LLC | 4,285 | $239.0K | 0.00% |
| Lazard Asset Management LLC | 2,157 | $120.0K | 0.00% |
| Carroll Financial Associates, Inc. | 33 | $1.00K | 0.00% |
Sold out (9)
Institutions that held Eagle Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pacer Advisors, Inc. | 25,434 | $1.09M |
| Exchange Traded Concepts, LLC | 22,897 | $980.0K |
| Engineers Gate Manager LP | 10,034 | $429.0K |
| 6 Meridian | 8,157 | $349.0K |
| Jump Financial, LLC | 6,600 | $282.0K |
| Zebra Capital Management LLC | 6,472 | $277.0K |
| Squarepoint Ops LLC | 5,197 | $222.0K |
| Hershey Trust Co | 2,138 | $92.0K |
| Eubel Brady & Suttman Asset Management Inc | 2 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Eagle Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 8,195 | $351.0K |